Evidence map›Paper›PMID 36266777›Full record

ReviewVirulence2022

Pathogenicity & virulence of

Alessandro F Valdez, Daniel Zamith Miranda, Allan Jefferson Guimarães, Leonardo Nimrichter, Joshua D Nosanchuk

Open access · goldAbstract readReview
In one paragraph

Review in Virulence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 44 citations in OpenAlex.

  1. Observational
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Extracellular vesicles from DistinctACS infectious diseases · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Influence of Zinc onJournal of fungi (Basel, Switzerland) · 2024
    Article
  14. Histoplasmosis in Solid Organ Transplantation.Journal of fungi (Basel, Switzerland) · 2024
    Review
  15. Design of a Multi-Epitope Vaccine againstJournal of fungi (Basel, Switzerland) · 2024
    Article
  16. Common virulence factors betweenCurrent research in microbial sciences · 2024
    Review
  17. Review
  18. Antifungal Activity of Chitosan againstJournal of fungi (Basel, Switzerland) · 2023
    Article
  19. Traversing the Cell Wall: The Chitinolytic Activity ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Alessandro F ValdezDepartamento de Microbiologia Geral, Universidade Federal do Rio de Janeiro, Instituto de Microbiologia Paulo de Góes, Rio de Janeiro, Brazil.
Daniel Zamith MirandaDepartments of Medicine (Division of Infectious Diseases) and Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA.
Allan Jefferson GuimarãesDepartamento de Microbiologia e Parasitologia - MIP, Universidade Federal Fluminense, Instituto Biomédico, Rio de Janeiro, Brazil.
Leonardo NimrichterDepartamento de Microbiologia Geral, Universidade Federal do Rio de Janeiro, Instituto de Microbiologia Paulo de Góes, Rio de Janeiro, Brazil.
Joshua D NosanchukDepartments of Medicine (Division of Infectious Diseases) and Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA.ORCID 0000-0001-9905-5754
Albert Einstein College of Medicine · USUniversidade Federal do Rio de Janeiro · BRUniversidade Federal Fluminense · BR

Funding

Antibody differentially alters Histoplasma extracellular vesiclesR21AI124797 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI NOSANCHUK, JOSHUA D · 2016 to 2017
$538k
NIAID NIH HHS R21 AI124797
6 · The paper itself

Abstract

Histoplasmosis is a systemic mycosis caused by the thermally dimorphic fungus

Indexed as

HistoplasmaHistoplasmosisAdaptation, PhysiologicalAnimalsHumansMammalsVirulenceVirulence FactorsVirulence FactorsdimorphismHistoplasma capsulatumhistoplasmosisintracellular parasitismvirulence

Identifiers

PMID36266777
PMCPMC9621017
OpenAlexW4306936874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.